SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-21-016301
Filing Date
2021-02-09
Accepted
2021-02-09 06:24:25
Documents
1
Group Members
DCVC BIO GP, LLCJNK CAPITAL MANAGEMENT, LLCJOHN HAMERKIERSTEN STEADMATTHEW OCKOZACHARY BOGUEZNM CAPITAL MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G tm215137d1_sc13g.htm SC 13G 223696
  Complete submission text file 0001104659-21-016301.txt   225378
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Subject) CIK: 0001703057 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91923 | Film No.: 21603864
SIC: 2834 Pharmaceutical Preparations

Mailing Address 317 UNIVERSITY AVENUE, SUITE 200 PALO ALTO CA 94301
Business Address 317 UNIVERSITY AVENUE, SUITE 200 PALO ALTO CA 94301 415-840-7337
DCVC Bio, L.P. (Filed by) CIK: 0001735069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G